Clinical Trials Directory

Trials / Completed

CompletedNCT03888833

Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation

Risk Factors of Bleeding in Patients Undergoing Peripheral Veno Arterial Extra Corporeal Membrane Oxygenation

Status
Completed
Phase
Study type
Observational
Enrollment
278 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Veno arterial extracorporeal membrane oxygenation (VA ECMO) is used, for cardiogenic shock, refractory cardiac arrest and post cardiotomy cardiac failure. Bleeding is frequent complications during VA ECMO and is associated with increased mortality. The aim of our study was to identify early factors associated with major bleeding in patients supported by VA ECMO

Conditions

Interventions

TypeNameDescription
DEVICEECMOECMO installation

Timeline

Start date
2006-04-01
Primary completion
2016-12-01
Completion
2018-01-01
First posted
2019-03-25
Last updated
2026-02-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03888833. Inclusion in this directory is not an endorsement.

Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation (NCT03888833) · Clinical Trials Directory